HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alena Gros Selected Research

Interferon-gamma (Interferon, gamma)

1/2021Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alena Gros Research Topics

Disease

29Neoplasms (Cancer)
01/2021 - 09/2006
6Melanoma (Melanoma, Malignant)
01/2016 - 07/2010
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2015 - 09/2013
3Neoplasm Metastasis (Metastasis)
01/2014 - 06/2009
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2009 - 06/2009
1Necrosis
01/2016
1Penile Neoplasms (Penile Cancer)
10/2015
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2015
1Anus Neoplasms (Anal Cancer)
10/2015
1Cholangiocarcinoma
05/2014
1Stomach Neoplasms (Stomach Cancer)
01/2014
1Adenocarcinoma
01/2014
1Carcinoma (Carcinomatosis)
09/2012
1Thrombocytopenia (Thrombopenia)
09/2012

Drug/Important Bio-Agent (IBA)

6T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2019 - 02/2013
6AntigensIBA
05/2017 - 05/2014
3Neoplasm Antigens (Tumor Antigens)IBA
04/2016 - 01/2016
2VaccinesIBA
01/2019 - 03/2017
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2019 - 12/2015
2EpitopesIBA
12/2015 - 10/2015
2CytokinesIBA
01/2015 - 09/2012
2Proteins (Proteins, Gene)FDA Link
05/2014 - 09/2006
1Interferon-gamma (Interferon, gamma)IBA
01/2021
1Bispecific AntibodiesIBA
01/2021
1Interleukin-12 (IL 12)IBA
12/2019
1Peptides (Polypeptides)IBA
01/2019
1RNA (Ribonucleic Acid)IBA
05/2017
1atezolizumabIBA
03/2017
1pembrolizumabIBA
03/2017
1IpilimumabIBA
03/2017
1NivolumabIBA
03/2017
1Immune Checkpoint InhibitorsIBA
03/2017
1Kv1.3 Potassium ChannelIBA
01/2016
1IonsIBA
01/2016
1DNA (Deoxyribonucleic Acid)IBA
01/2016
1PotassiumIBA
01/2016
1HLA-A Antigens (HLA-A)IBA
10/2015
1Oncogene Proteins (Oncogene Protein)IBA
10/2015
1VemurafenibIBA
01/2015
1MucinsIBA
05/2014
1Biomarkers (Surrogate Marker)IBA
05/2014
1Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA
05/2014
1Immunoglobulins (Immunoglobulin)IBA
05/2014
1HLA-C Antigens (HLA-C)IBA
01/2014
1HLA-B Antigens (HLA-B)IBA
01/2014
1Interleukin-2 (IL2)IBA
09/2013
1SuspensionsIBA
10/2012
1Alanine Transaminase (SGPT)IBA
09/2012
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
09/2012
1IntegrinsIBA
09/2012
1Complementary DNA (cDNA)IBA
07/2010
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
07/2010
1Hyaluronic Acid (Hyaluronan)IBA
07/2010
1Verapamil (Calan)FDA LinkGeneric
05/2010
1Thymidine KinaseIBA
11/2009
1Docetaxel (Taxotere)FDA Link
11/2009
1arginyl-glycyl-aspartic acidIBA
10/2009
1Sulfates (Sulfates, Inorganic)IBA
10/2009
1Heparin (Liquaemin)FDA LinkGeneric
10/2009
1LigandsIBA
10/2009
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
10/2009
1Urokinase Plasminogen Activator ReceptorsIBA
06/2009
1adenovirus associated RNA (VA RNA)IBA
09/2006
1Messenger RNA (mRNA)IBA
09/2006

Therapy/Procedure

15Therapeutics
01/2021 - 06/2009
12Immunotherapy
01/2021 - 01/2014
3Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021 - 02/2013
1Aftercare (After-Treatment)
01/2016
1Drug Therapy (Chemotherapy)
01/2014